Smith & Nephew plc (LON:SN.)

Market Cap	9.01B
Revenue (ttm)	4.46B
Net Income (ttm)	241.34M
Shares Out	872.00M
EPS (ttm)	0.28
PE Ratio	37.42
Forward PE	13.97
Dividend	0.30 (2.92%)
Ex-Dividend Date	Oct 3, 2024

Volume	2,435,276
Average Volume	1,559,560
Open	1,015.00
Previous Close	1,017.50
Day's Range	1,011.00 - 1,037.00
52-Week Range	8.87 - 12.45
Beta	0.70
RSI	56.91
Earnings Date	Feb 25, 2025

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1856
• Employees: 18,452
• Stock Exchange: London Stock Exchange
• Ticker Symbol: SN.

Financial Performance

In 2023, Smith & Nephew's revenue was $5.55 billion, an increase of 6.40% compared to the previous year's $5.22 billion. Earnings were $263.00 million, an increase of 17.94%.

Financial numbers in USD